FDA, FTC warn companies for selling illegal, unapproved opioid cessation products using deceptive claims
The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help …